Latest BioAlps news
News
Volumina Medical Gets a CHF 500 000 Loan from FIT
Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of…
News
Switzerland accepts medical devices with FDA approval
The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate /…
News
EUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)
The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList….
News
Limula wins the start-up Swiss Technology Award
During the Swiss Innovation Forum on 23 November 2022 in Basel, Limula won the Inventor Award. Two other companies…
News
CERN, CHUV and THERYQ develop a revolutionary FLASH radiotherapy device to fight cancer
This FLASH radiotherapy device will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with…
News
Prof. Jocelyne Bloch and Prof. Grégoire Courtine receive the BioAlps Academia Award, and Incyte the BioAlps Industry Award.
The ceremony closed the BioAlps Networking Day on 24 November 2022 in Neuchâtel, in front of 250 key players of…
News
Dentsply Sirona wins the Vaud International Business Award
The dental products world leader employs 700 people in the canton. Each fall, the Vaud International Business…
News
ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in…
News
Opna Bio Raises $38M in Series A Financing
Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round…
News
Claude Nicollier steps down from his position as CSEM
The former astronaut has spent 16 years as Chairperson of the Board of Directors Effective June 2023, Claude Nicollier…
News
Novigenix announces first closing of its $20M Series B
The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient…
News
Neuria receives the Start-Up Innovation Prize of the Canton of Fribourg
Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders …
Latest Republic of Innovation news
